News Room

The U.S. celebrated when new coronavirus vaccines were developed at record-breaking speed. And in December the candidates from Pfizer and BioNTech and Moderna were quickly approved for emergency use by the Food and Drug Administration. But two months later, only 10 percent of Americans have received at least one shot. And fewer than 3 percent of them have received both of the necessary doses. Many feel frustrated with the slow distribution process and confused about how to sign up for shots. What exactly is making all this take so long?

The US celebrated when new coronavirus vaccines were developed at record-breaking speed. And in December the candidates from Pfizer and BioNTech and Moderna were quickly approved for emergency use by the Food and Drug Administration. But two months later, only 10 per cent of Americans have received at least one shot. And fewer than 3 per cent of them have received both of the necessary doses. Many feel frustrated with the slow distribution process and confused about how to sign up for shots. What exactly is making all this take so long?

The affluent town of Woodbridge, Conn., has less than half the population of neighboring Ansonia, and yet it’s home to more people who have received a Covid-19 vaccine. The inequity is stark: In Woodbridge, where residents have a median household income of $138,320 a year, 19.3% of the population had been vaccinated as of Feb. 4, according to Connecticut health department data. In Ansonia, where the median income is $45,563 a year, just 7.1% have received their first shot. Connecticut has the most glaring disparity in vaccination rates between its richest and poorest communities — a difference of 65% — according to a STAT analysis of local-level vaccine data in 10 states with the biggest wealth gaps.

We have been focused, as a nation and a world community, on developing and distributing a COVID-19 vaccine since the virus first emerged more than a year ago. But now that millions are getting their first dose, we’re learning that this is not a silver bullet. Mae spoke to Professor Julie Swann about how our lives will gradually return to normal.

The COVID-19 vaccine rollout has been a nightmare for many Americans as they struggle through multi-step registration and appointment systems. The federal government had envisioned states using one national vaccine scheduling system, and it offered a contractor $44 million to develop it. But that system turned out to be so poorly designed that all but nine states opted out before even trying to adopt it, even though it was being offered by the government for free.